Cargando…
Correction to: MIIP inhibits the growth of prostate cancer via interaction with PP1α and negative modulation of AKT signaling
Autores principales: | Yan, Guang, Ru, Yi, Yan, Fengqi, Xiong, Xin, Hu, Wei, Pan, Tao, Sun, Jianming, Zhang, Chi, Wang, Qinhao, Li, Xia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6802316/ https://www.ncbi.nlm.nih.gov/pubmed/31639006 http://dx.doi.org/10.1186/s12964-019-0441-4 |
Ejemplares similares
-
MIIP inhibits the growth of prostate cancer via interaction with PP1α and negative modulation of AKT signaling
por: Yan, Guang, et al.
Publicado: (2019) -
MIIP inhibits clear cell renal cell carcinoma proliferation and angiogenesis via negative modulation of the HIF-2α-CYR61 axis
por: Yan, Fengqi, et al.
Publicado: (2022) -
MiIP: The Monomer Identification and Isolation Program
por: Bun, Christopher, et al.
Publicado: (2012) -
Correction: Lapatinib inhibits CIP2A/PP2A/p-Akt signaling and induces apoptosis in triple negative breast cancer cells
por: Liu, Chun-Yu, et al.
Publicado: (2017) -
MIIP functions as a novel ligand for ITGB3 to inhibit angiogenesis and tumorigenesis of triple-negative breast cancer
por: Gao, Yujing, et al.
Publicado: (2022)